Steve C. Glover

Director, AURIGA LABORATORIES, INC.

Companies

Oncolytics BiotechBoard member Jun 3, 2026 to now¹
ZyVersa Therapeutics, Inc.Board member Dec 13, 2022 to now²
ZyVersa Therapeutics, Inc.Chief executive officer Dec 13, 2022 to now²
PDS Biotechnology CorpBoard member Apr 10, 2019 to now³
Ambrx Biopharma, Inc.Board member Mar 7, 2024 to Mar 7, 2024⁴
Ambrx Biopharma Cayman, Inc.Board member May 19, 2023 to Jun 9, 2023⁵
INSMED IncPresident Jun 26, 2007 to Apr 2, 2009⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

PDS Biotechnology Corp PDSB78,851 shares⁷$75.9K at $0.96Feb 28, 2025
ZyVersa Therapeutics, Inc. ZVSA492,756 shares⁸$23.7K at $0.05Dec 12, 2022
Ambrx Biopharma Cayman, Inc.85,000 shares⁹Jun 7, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 28, 2025Bought 15,061 shares at $1.66 of PDS Biotechnology Corp⁷
Jun 7, 2023Granted 85,000 shares of Ambrx Biopharma Cayman, Inc.⁹
Dec 12, 2022Granted 43,847 shares of ZyVersa Therapeutics, Inc.⁸
Dec 12, 2022Granted 49,636 shares of ZyVersa Therapeutics, Inc.⁸
Dec 12, 2022Granted 85,442 shares of ZyVersa Therapeutics, Inc.⁸
Dec 12, 2022Granted 448,909 shares of ZyVersa Therapeutics, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROncolytics Biotech, Board member
2
SEC EDGARZyVersa Therapeutics, Inc., Board member
3
SEC EDGARPDS Biotechnology Corp, Board member
4
SEC EDGARAmbrx Biopharma, Inc., Board member
5
SEC EDGARAmbrx Biopharma Cayman, Inc., Board member
6
SEC EDGARINSMED Inc, President
7
SEC EDGARPDS Biotechnology Corp shares after the filing of Feb 28, 2025
8
SEC EDGARZyVersa Therapeutics, Inc. shares after the filing of Dec 12, 2022
9
SEC EDGARAmbrx Biopharma Cayman, Inc. shares after the filing of Jun 7, 2023